Subscribe To
Autolus Therapeutics announces Board changes
LONDON, Jan. 20, 2023 (GLOBE NEWSWIRE) — Autolus Therapeutics plc (Nasdaq: AUTL), a clinical-stage biopharmaceutical company developing next-generation programmed T cell therapies, announces two changes to the company’s Board of Directors. The company’s non-executive Chairman, John H Johnson, who has held the role since September 2021, will not stand for re-election at Autolus’ upcoming annual shareholder […] The post Autolus Therapeutics announces Board changes appeared first on ForexTV...
Read More
Posted: Jan 20 2023, 12:00
Author Name: forextv
Views: 111722